Dr. B. Pleasure Snider, a professor of neurology at Washington University University of Medicine who is involved with trials with the medications and Beforehand served to be a advisor to each Eisai and Lilly, explained the slowing of decline was “not a massive distinction,” but could be meaningful in people today’s lives — as an example, by